Expected outcomes at the 6-month mark include: 10 to 20% reduction in visceral fat (measurable via DEXA scan), improved fasting glucose and insulin sensitivity, measurably thicker skin with better elasticity, stronger hair and nail growth, 15 to 25% improvement in IGF-1 above baseline, enhanced exercise capacity and faster recovery, and improved cognitive clarity and focus
OrderlyMeds Discount Code Use code MATCH to save $25 on your first order
doi: 10.1038/s41467-017-02797-2 137 KauffmanASParkJHMcPhie-LalmansinghAAGottschMLBodoCHohmannJGet al
Available agents include daily and once-weekly long-acting formulations such as liraglutide and others 11,12
These clinical findings also noted the normalization of fasting glucose levels, baseline reductions in insulin doses, and improvement in preexisting insulin resistance